Products associated with the muscle spasticity market include botulinum toxin, baclofen, diazepam and others. Botulinum toxin injections temporarily paralyze overactive muscles to reduce stiffness and pain. The global Muscle Spasticity Market is estimated to be valued at US$ 5,693.7 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing number of cases of neurological disorders such as cerebral palsy, multiple sclerosis and spinal cord injuries is one of the major factors driving the growth of the Global Muscle Spasticity Market Size. According to the National Multiple Sclerosis Society (NMSS), approximately 1 million people in the United States are living with multiple sclerosis and their risk of developing spasticity increases with disease duration and progression. Such a high prevalence of neurological disorders requiring muscle spasticity management is contributing to the market growth significantly. Investments by key players in the development of advanced treatment options and rehabilitation programs for spasticity are also fueling the market growth over the forecast period.
Segment Analysis
The global muscle spasticity market can be segmented by type, therapeutics, and end user. Among the type segment, spastic hemiplegia dominates the global market. Spastic hemiplegia is caused by injury to one side of the brain, which controls voluntary muscle contractions on the opposite side of the body. Due to such unilateral brain injury, spastic hemiplegia affects movement on one half of the body, making it the most common type of spasticity.
Key Takeaways
The global muscle spasticity market is expected to witness high growth during the forecast period of 2024 to 2031. The market size for 2024 is US$ 5693.7 Mn.
Regional Analysis: North America dominates the global muscle spasticity market and is expected to continue its dominance during the forecast period. The high prevalence of spasticity disorders such as cerebral palsy and multiple sclerosis is a major factor contributing to North America's large market share. Additionally, the region has a highly developed healthcare system and the presence of key pharmaceutical companies drives the growth of the regional market.
Key players operating in the muscle spasticity market are Accenture PLC,Cisco Systems Inc.,Cognizant Technology Solutions Corporation,Capgemini,Computer Sciences Corporation (CSC),HCL Technologies Ltd.,IBM Corporation,Infosys Ltd.,Intel Corporation,Jabil Circuits,Micron Technology,NTT Data Corporation,Tata Consultancy Services,Tech Mahindra Ltd.,Wipro Ltd.
Get More Insights On This Topic: https://www.newsstatix.com/muscle-spasticity-market-size-share-analysis-2023-2030/
Comments
0 comment